Journal of Neurology

, Volume 266, Issue 5, pp 1267–1269 | Cite as

Resolution of apathy after dorsal instead of ventral subthalamic deep brain stimulation for Parkinson’s disease

  • Thomas J. ZoonEmail author
  • Rob M. de Bie
  • P. Richard Schuurman
  • Pepijn van den Munckhof
  • Damiaan Denys
  • Martijn Figee
Letter to the Editors

Dear Sirs,

Subthalamic deep brain stimulation (STN DBS) is an effective treatment for advanced Parkinson’s disease (PD). The prevalence of apathy, i.e., loss of motivation and energy, after STN DBS in the previous studies is high, ranging between 21 and 71%, and is associated with a decreased quality of life [1, 2, 3, 4, 5, 6]. Neuro-imaging studies suggest a possible explanation for these symptoms because of an association between STN DBS-related apathy and stimulation of non-motor limbic circuits in the ventral region of the STN [7, 8, 9]. In this study, we describe three PD patients with STN DBS-related apathy who experienced a fast resolution of symptoms after switching stimulation from ventral to dorsal STN stimulation.

Bilateral electrodes (model 3389, Medtronic) were implanted in the STN under local anesthesia, followed by the placement of a pulse generator (Activa PC model 37,601, Medtronic) into the chest wall and post-surgical optimization of the stimulation settings [10]....


Compliance with ethical standards

Conflicts of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Ethical standards

All studies in this case study have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.


  1. 1.
    Marin RS (1991) Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 3:243–254CrossRefGoogle Scholar
  2. 2.
    Starkstein SE (2012) Apathy in Parkinson’s disease: diagnostic and etiological dilemmas. Mov Disord 2:174–178CrossRefGoogle Scholar
  3. 3.
    Higuchi MA, Tsuboi Y, Inoue T, Fukuyama K, Abe H, Baba Y, Yamada T (2015) Predictors of the emergence of apathy after bilateral stimulation of the subthalamic nucleus in patients with Parkinson’s disease. Neuromodulation 18:113–117CrossRefGoogle Scholar
  4. 4.
    Ricciardi L, Morgante L, Epifanio A, Zibetti M, Lanotte M, Lopiano L, Morgante F (2014) Stimulation of the subthalamic area modulating movement and behavior. Parkinsonism Rel Disord 20(11):1298–1300CrossRefGoogle Scholar
  5. 5.
    Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello T et al (2009) The Priamo study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 24(11):1641–1649CrossRefGoogle Scholar
  6. 6.
    Thobois S, Ardouin C, Lhommée E, Klinger H, Lagrange C, Xie J et al (2010) Non-motor dopamine withdrawal syndrome after surgery for Parkinson’s disease: predictors and underlying mesolimbic denervation. Brain 133:1111–1127CrossRefGoogle Scholar
  7. 7.
    Drapier D, Drapier S, Sauleau P, Haegelen C, Raoul S, Biseul I et al (2006) Does subthalamic nucleus stimulation induce apathy in Parkinson’s disease? J Neurol 253:1083–1091CrossRefGoogle Scholar
  8. 8.
    Le Jeune F, Drapier D, Bourguignon A, Péron J, Mesbah H, Drapier S et al (2009) Subthalamic nucleus stimulation in Parkinson disease induces apathy. A PET study. Neurology 73:1746–1751CrossRefGoogle Scholar
  9. 9.
    Stefurak T, Mikulis D, Mayberg H, Lang A, Hevenor S, Pahapill P et al (2003) Deep brain stimulation for Parkinson’s disease dissociates mood and motor circuits: a functional MRI case study. Mov Disord 18(12):1508–1516CrossRefGoogle Scholar
  10. 10.
    Odekerken VJJ, van Laar T, Staal MJ, Mosch A, Hoffman CFE, Nijssen PCG et al (2013) Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson’s disease (NSTAPS study): a randomized controlled trial. Lancet Neurol 12(1):37–44CrossRefGoogle Scholar
  11. 11.
    Czernecki V, Schüpbach M, Yaici S, Lévy R, Bardinet E, Yelnik J et al (2008) Apathy following subthalamic stimulation in Parkinson’s disease: a dopamine responsive syndrome. Mov Disord 23:964–969CrossRefGoogle Scholar
  12. 12.
    Temel Y, Kessels A, Tan S, Topdag A, Boon P, Visser-Vandewalle V (2006) Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: a systematic review. Parkinsonism Relat Disord 12:265–272CrossRefGoogle Scholar
  13. 13.
    Solla P, Fasano A, Cannas A, Mulas CS, Marrosu MG, Lang AE, Marrosu F (2015) Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson’s disease patients treated with levodopa–carbidopa intestinal gel infusion. Parkinsonism Relat Disord 21(8): 968–971CrossRefGoogle Scholar
  14. 14.
    Robert GH, Le Jeune F, Lozachmeur C, Drapier S, Dondaine T, Péron J et al (2014) Preoperative factors of apathy in subthalamic stimulated Parkinson disease. A PET study. Neurology 83(18): 1620–1626CrossRefGoogle Scholar
  15. 15.
    Okun MS, Wu SS, Fayad S, Ward H, Bowers D, Rosado C et al (2014) Acute and chronic mood and apathy outcomes from a randomized study of unilateral STN and GPi DBS. PLoS One 9(12):e114140CrossRefGoogle Scholar
  16. 16.
    Hilker R, Voges J, Weisenbach S, Kalbe E, Burghaus L, Ghaemi M et al (2004) Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson’s disease. J Cereb Blood Flow Metab 24:7–16CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Thomas J. Zoon
    • 1
    Email author
  • Rob M. de Bie
    • 2
  • P. Richard Schuurman
    • 3
  • Pepijn van den Munckhof
    • 3
  • Damiaan Denys
    • 1
  • Martijn Figee
    • 1
    • 4
  1. 1.Department of PsychiatryAmsterdam University Medical CenterAmsterdamThe Netherlands
  2. 2.Department of NeurologyAmsterdam University Medical CenterAmsterdamThe Netherlands
  3. 3.Department of NeurosurgeryAmsterdam University Medical CenterAmsterdamThe Netherlands
  4. 4.Department of PsychiatryIcahn School of Medicine at Mount SinaiNew YorkUSA

Personalised recommendations